3^rd Congressional Seminar:
Considerations for the 2012 Reauthorization of PAHPA

Overview

On March 1, 2012, the Center for Biosecurity of UPMC and the Biotechnology Industry Organization (BIO) convened Congressional staff, government officials, biosecurity organizations, and key stakeholders to discuss the importance of reauthorizing the Pandemic and All-Hazards Preparedness Act (PAHPA). With a standing room only audience of more than 100 attendees, the response to this issue was impressive, with significant numbers of both Congressional staff and members of the biosecurity community at large in attendance for a lively, informative meeting.

Learn more about PAHPA: http://www.phe.gov/preparedness/legal/pahpa/pages/default.aspx

More Events in the Center for Biosecurity Congressional Seminar Series

• US Preparedness for a Nuclear Detonation, October 17, 2011

• Considerations for the 2011 Reauthorization of PAHPA, March 25, 2011

The series honorary co-host is the Senate Caucus on WMD Terrorism

Agenda

Welcome and Introductions

• Scott Whitaker, Chief Operating Officer, Biotechnology Industry Organization (BIO)

Opening Remarks

• Senator Robert P. Casey, Jr., US Senator, Pennsylvania

• Congressman Mike Rogers, US Representative for Michigan's 8th Congressional District

Panel 1: Biological Threats and Current Challenges

• Robert Kadlec, Former Special Assistant to the President for Homeland Security and Senior Director for Biological Defense Policy; Vice President, PRTM, Moderator

• Philip K. Russell, Former Senior Advisor, Office of the Assistant Secretary for Public Health Emergency Preparedness, US Department of Health and Human Services

• Lynne Kidder, President, The WMD Center

Panel 2: The Importance of Reauthorizing PAHPA

• Tom Inglesby, CEO and Director, Center for Biosecurity of UPMC, Moderator

• Brian Kamoie, Senior Director for Preparedness Policy, National Security Staff, Executive Office of the President

• Ali Khan, Director, Office of Public Health Preparedness and Response, US Centers for Disease Control and Prevention

• Richard Hatchett, Chief Medical Officer and Deputy Director for Strategic Sciences, Biomedical Advanced Research and Development Authority (BARDA), Office of the Assistant Secretary for Preparedness and Response (ASPR), US Department of Health and Human Services

• Jesse Goodman, Chief Scientist, Office of the Chief Scientist, U.S. Food and Drug Administration (FDA)

Closing Remarks

• Tom Inglesby, CEO and Director, Center for Biosecurity of UPMC

Speakers

Conference Photos

Lynn Kidder and Philip K. Russell

L to R: Phyllis Arthur, Richard Hatchett, and Ali Khan

Congressman Mike Rogers

Senator Robert Casey

Rhilip K. Russell